信息搜索
信息关键字:医
 
『查询2022年信息』  『查询2021年信息』  『查询2020年信息』  『查询2019年信息』  『查询2018年信息』  『查询2017年信息』  『查询2016年信息』
『查询2015年信息』  『查询2014年信息』  『查询2013年信息』  『查询2012年信息』  『查询2011年信息』  『查询2010年信息』  『查询2009年信息』

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165]

·A股“铁公鸡”曝光,最长29年未分红送转!百花医药融资是分红的465倍2023-11-17 21:46:27
·迪哲医药:国际权威期刊《药物》发表舒沃哲?获批信息和关键数据综述2023-11-17 21:30:03
·恒瑞医药:耗资624662597.16元回购股份14112323股2023-11-17 20:43:53
·迪哲医药:国际权威期刊发表舒沃哲获批信息和关键数据综述2023-11-17 20:26:50
·景峰医药:公司预重整债权申报通知2023-11-17 19:14:46
·宣泰医药:公司产品中选第九批国家组织药品集中带量采购2023-11-17 18:20:53
·11月17日延华智能涨停分析:体外诊断,物联网,医疗信息化概念热股2023-11-17 17:28:11
·11月17日西陇科学涨停分析:基因测序,新能源汽车,医疗器械概念热股2023-11-17 16:33:06
·宣泰医药:公司产品中选国家组织药品集中带量采购2023-11-17 16:07:50
·工信部:开展“5G+工业互联网”创新应用,加快医药工业“智改数转”2023-11-17 15:26:08
·收评:沪指震荡微涨,汽车产业链股活跃,半导体、医药等板块拉升2023-11-17 15:17:19
·亿帆医药宣布艾贝格司亭α注射液在美国获批上市2023-11-17 14:10:28
·百万元CAR-T细胞疗法未入围医保谈判名单2023-11-17 13:45:56
·医药股午后异动 亿帆医药涨超9%2023-11-17 13:07:46
·国家中医药管理局副局长王志勇:进一步强化中医药发展政策供给2023-11-17 11:56:25
·亿帆医药:控股子公司在研产品艾贝格司亭α注射液获FDA批准上市2023-11-17 11:47:37
·百诚医药(301096)11月16日主力资金净卖出590.40万元2023-11-17 10:58:29
·2023国家医保谈判打响 首轮至少两家企业出现2023-11-17 9:58:24
·我国规模以上医药工业企业超过1万家2023-11-17 9:49:59
·厦门:面向社会提供医疗服务的各级各类医疗机构均应执行价格公示制度2023-11-17 9:33:17

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165]